Julie Kim

Julie Kim is an accomplished leader in the pharmaceutical and life sciences industry, currently serving as Chief Business Officer at Lyterian Therapeutics since September 2024. Previous roles include Chief Business Officer and Senior Vice President of Corporate Strategy & Business Development at Walking Fish Therapeutics, Inc. from January 2022 to March 2024, and various positions at Arcellx, Inc., Quan Capital 泉创资本, Genentech, and Roche Pharmaceutical Research & Early Development. Julie has extensive experience in business development, portfolio management, and strategic partnerships, complemented by a solid educational background including a Doctor of Pharmacy from UC San Diego, a Master's in Chemistry from the University of San Francisco, and a Bachelor's in Music and Chemistry from Emory University.